Treatment with an IRE1α inhibitor inhibited PCa growth in vitro and in vivo, indicating that the IRE1α/XBP1 pathway promotes PCa through activation of c-MYC signalling [50]. Here, ERN1 is linked to posterior cortical atrophy.